How big is the prosthetic heart valve devices and equipment market today, and what are its future growth expectations?
The prosthetic heart valve devices and equipment market size has grown rapidly in recent years. It will grow from $6.68 billion in 2024 to $7.44 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to cardiovascular disease prevalence, aging population, chronic disease management, clinical guidelines and research.
The prosthetic heart valve devices and equipment market size is expected to see strong growth in the next few years. It will grow to $10.39 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to minimally invasive procedures, telehealth integration, global access to healthcare, drug-coated devices. Major trends in the forecast period include artificial intelligence (ai) in vascular medicine, robot-assisted interventions, point-of-care testing, bioresorbable vascular scaffolds.
Get Your Free Sample of The Global Prosthetic Heart Valve Devices And Equipment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2416&type=smp
What have been the primary factors driving the prosthetic heart valve devices and equipment market’s growth?
The rising prevalence of valvular heart disease has driven the need for transcatheter aortic valve replacement (TAVR) procedures, thus driving the prosthetic heart valve devices and equipment market. TAVR is a minimally-invasive surgical procedure done to cure aortic stenosis which is a valvular heart disease that affects the aortic valve of the heart. Aortic stenosis affects the aortic valve by hardening it, thus not allowing blood to properly flow through it and TAVR is used to replace this defective aortic valve with a transcatheter valve. For instance, in May 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2022, heart disease caused 702,880 deaths in the United States, accounting for 1 in every 5 fatalities. As the rate of occurrence of valvular heart diseases rises, the number of TAVR procedures done can be expected to increase which also increases the demand for transcatheter valves, thus driving the market going forward.
What are the key segments within the prosthetic heart valve devices and equipment market?
The prosthetic heart valve devices and equipment market covered in this report is segmented –
1) By Product Type: Repair Products, Mitral Valve Repair Devices, Tricuspid Valve Repair Devices
2) By Type: Transcatheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve
3) By Technology: Biological Valve, Decellularized Valve
4) By Application: Hospitals, Ambulatory Surgery Centres
Subsegments:
1) By Repair Products: Transcatheter Mitral Valve Repair (TMVR) Devices, Transcatheter Tricuspid Valve Repair (TTVR) Devices
2) By Mitral Valve Repair Devices: Mitral Valve Repair Systems (MitraClip), Mitral Valve Annuloplasty Devices, Edge-to-Edge Repair Devices
3) By Tricuspid Valve Repair Devices: Tricuspid Valve Annuloplasty Devices, Tricuspid Valve Repair Systems
Order your report now for swift delivery
Which key players are shaping the prosthetic heart valve devices and equipment market?
Major companies operating in the prosthetic heart valve devices and equipment market include Boston Scientific Corporation, Edwards Lifesciences, Medtronic plc, LivaNova plc, Abbott Laboratories, Jenavalve Technology Inc., Lepu Medical Technology, Cryolife Inc., Neovasc Inc., Braile Biomedica, Colibri Heart Valve, TTK Healthcare Ltd., Medical Technology Est., Micro Interventional Devices Inc., Well Health Technologies, On-X Life Technologies Inc., Meril Life Sciences Pvt. Ltd., Sorin Group, Commonwealth Edison Company, Cardiac Dimensions Inc., CardioSolutions Inc., Leman Cardiovascular, MitralSolutions Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Xeltis AG, Transcatheter Technologies GmbH, Venus Medtech (Hangzhou) Inc., MValve Technologies Ltd., MVRx Inc., NaviGate Cardiac Structures Inc., Pulmonx Corporation, Tendyne Holdings Inc., ValveXchange Inc., Vascutek Ltd., XpandOrtho Inc., Zhejiang A&F Medical Co. Ltd.
How will evolving trends contribute to the growth of the prosthetic heart valve devices and equipment market?
The prosthetic heart valve devices and equipment market is monitored by regulatory bodies such as FDA in the US and The Central Drugs Standard Control Organization (CDSCO). For instance, CDSCO issued a notice regarding the classification of the risk levels of different medical devices. Under this classification, prosthetic heart valves are considered a class D or high-risk device. Similarly, for manufacturers to produce and sell prosthetic valve devices in India, they need to sign forms MD-7 and MD-8 which come under the direct purview of the central government of India. Form MD-7 is used to register prosthetic valve manufacturers in India and form MD-8 is used by prosthetic valve manufacturers to apply for loans.
Which regional trends are influencing the prosthetic heart valve devices and equipment market, and which area dominates the industry?
North America was the largest region in global prosthetic heart valve devices and equipment market in 2023. Western Europe was the second-largest region in prosthetic heart valve devices and equipment market. The regions covered in the prosthetic heart valve devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does The Prosthetic Heart Valve Devices And Equipment Market Report 2025 Offer?
The prosthetic heart valve devices and equipment market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Prosthetic heart valve devices and equipment are artificial heart valves that are implanted in the heart of a patient with valvular heart disease. They are used to regulate blood flow within the heart, improving circulation and overall heart function. These devices can be mechanical or biological, offering patients options based on their specific medical needs and conditions.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2416
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
